Sage Therapeutics Other Current Liabilities

Sage Therapeutics (SAGE) currently reports a other current liabilities of $41M as of June 2025. That compares with $59M in the prior-year period — down 29.8% year over year. Use the charts on this page to explore Sage Therapeutics's other current liabilities history and peer comparisons.

Sage Therapeutics's other current liabilities decreased from $59M to $41M — a 29.8% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sage Therapeutics reported $41M in other current liabilities as of June 2025. That compares with $59M in the prior-year period — down 29.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $41M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sage Therapeutics, and consider following SAGE for alerts when major investors trade the stock.

Sage Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $41M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SAGE with unrelated industries.